Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-12,519
Closed -$3.08M 1037
2022
Q3
$3.08M Sell
12,519
-1,805
-13% -$487K 0.02% 644
2022
Q2
$3.54M Sell
14,324
-1,359
-9% -$367K 0.02% 657
2022
Q1
$5.2M Sell
15,683
-5,274
-25% -$1.62M 0.03% 588
2021
Q4
$7.53M Buy
20,957
+2,920
+16% +$987K 0.03% 476
2021
Q3
$5.87M Buy
18,037
+3,174
+21% +$1.08M 0.03% 537
2021
Q2
$4.64M Sell
14,863
-3,802
-20% -$1.17M 0.02% 613
2021
Q1
$5.95M Sell
18,665
-575
-3% -$184K 0.03% 483
2020
Q4
$6.24M Sell
19,240
-3,546
-16% -$981K 0.03% 445
2020
Q3
$6.31M Sell
22,786
-1,458
-6% -$420K 0.04% 392
2020
Q2
$5.86M Sell
24,244
-16,385
-40% -$3.29M 0.04% 393
2020
Q1
$5.9M Buy
40,629
+14,959
+58% +$2.48M 0.04% 367
2019
Q4
$4.38M Buy
25,670
+9,981
+64% +$1.85M 0.03% 501
2019
Q3
$2.79M Sell
15,689
-103
-0.7% -$22.3K 0.02% 569
2019
Q2
$4.11M Sell
15,792
-314
-2% -$83.3K 0.03% 504
2019
Q1
$4.6M Buy
16,106
+122
+0.8% +$40.5K 0.03% 483
2018
Q4
$5.2M Sell
15,984
-4,543
-22% -$1.58M 0.04% 411
2018
Q3
$9.23M Buy
+20,527
New +$8.09M 0.05% 353

Other funds holding ABMD

Aviva's ABMD Position: Q4 2022 in Review

Aviva sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 12,519 shares — an estimated $3.08M sold.

Aviva first reported a position in ABMD in Q3 2018 and held it in 17 quarters. The position peaked at $9.23M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Aviva reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Aviva sold 12,519 Abiomed Inc shares in Q4 2022, an estimated $3.08M.
  • Aviva first reported a position in Abiomed Inc in Q3 2018 and held it in 17 quarters.
  • Aviva's Abiomed Inc position peaked at $9.23M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Aviva's 13F filing for Q4 2022, filed 9 Feb 2023.